<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01683305</url>
  </required_header>
  <id_info>
    <org_study_id>Silbiotech:2012-01</org_study_id>
    <nct_id>NCT01683305</nct_id>
  </id_info>
  <brief_title>Biomarker Breast Pap Test</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Silbiotech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Silbiotech</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a Phase I study. During the Phase I study, our goals are: 1) screen a number of
      cancer biomarkers in Nipple Aspirate Fluid (NAF) from women who have no mammographically
      detectable tumors, and those who have detectable tumors, 2) identify all the detectable
      markers and 3) establish that biomarkers detected in NAF could also be detected in the
      biopsied tumor tissue that was removed for diagnostic purpose in subjects who have detectable
      tumors.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Tumors</condition>
  <arm_group>
    <arm_group_label>Subjects who have no mammographically detectable tumors</arm_group_label>
    <description>This group will be evaluated for marker presence in NAF. no drugs administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subjects who have non-cancerous growths</arm_group_label>
    <description>This group will be evaluated to study whether marker(s) detected in NAF are also expressed in non-cancerous tumors. No drugs administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subjects who have cancerous growths</arm_group_label>
    <description>In this group, any markers detected in NAF could also be detected in tumor tissues. No drugs administered.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Any woman age 18 or older
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any female subject aged 18 years or older

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2012</study_first_submitted>
  <study_first_submitted_qc>September 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2012</study_first_posted>
  <last_update_submitted>September 10, 2012</last_update_submitted>
  <last_update_submitted_qc>September 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Silbiotech</investigator_affiliation>
    <investigator_full_name>Indira Poola, Ph.D</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>biomarker,</keyword>
  <keyword>NAF</keyword>
  <keyword>Subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

